ISSN: 2157-7013
Journal of Cell Science & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Development of an In vitro Cultivated, Spontaneously and Long-term Contracting 3D Heart Model as a Robust Test System

Bianka Grunow1*, Maren Schmidt1, Matthias Klinger2 and Charli Kruse1
1Fraunhofer Research Institution for Marine Biotechnology, Fraunhofer Society, Paul Ehrlich Str. 1-3, 23562, Lübeck, Germany
2University of Lübeck, Institute of Anatomy, Ratzeburger Allee 160, 23562, Lübeck, Germany
Corresponding Author : Bianka Grunow
Fraunhofer Research Institution for Marine Biotechnology
Fraunhofer Society, Paul Ehrlich Str. 1-3, 23562, Lübeck, Germany
Tel: +49-451-384448-16
Fax: +49-451-384448-12
E-mail:bianka.grunow@emb.fraunhofer.de
Received January 19, 2011; Accepted February 14, 2012; Published February 16, 2012
Citation: Grunow B, Schmidt M, Klinger M, Kruse C (2012) Development of an In vitro Cultivated, Spontaneously and Long-term Contracting 3D Heart Model as a Robust Test System. J Cell Sci Ther 3:116. doi: 10.4172/2157-7013.1000116
Copyright: © 2012 Grunow B, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Cell Science & Therapy

Abstract

Background: Beside its anti-proliferative, anti-hypertensive and anti-inflammatory effects, heparin has shown the apoptotic effect in lymphoblasts. In the study, it is aimed to show the apoptotic effect of heparin in lymphoblasts with measuring intracellular calcium and using DNA analysis by flow cytometry, in vitro. Methods: Twenty-three newly diagnosed acute lymphoblastic leukemia patients were included in the study. We added 10 and 20 U/ml heparin into the seperated lymphoblast samples and determined the percentages of apoptosis and intracellular Ca++ levels at 0, 1 and 2 hours by flow cytometry, in vitro. Results: The apoptotic effect on the lymphoblasts were established in 10 and 20 U/ml heparin concentrations at 0, 1 and 2 hours (p=0.005). The apoptotic effect of heparin in lymphoblasts was higher at the first hour than those at 0 and 2 hours in 10 and 20 U/ml heparin concentrations (p=0.005). The highest apoptosis was determined in 20 U/ml heparin concentration at the first hour. Statistically significant increase in intracellular Ca++ levels were determined in 10 and 20 U/ml heparin concentrations at 1 and 2 hours (p=0.005). In 10 and 20 U/ml heparin concentrations, intracellular Ca++ levels were significantly higher at the first hour than 0 and 2 hours (p=0.005). The highest intracellular Ca++ concentration was determined in 20 U/ml heparin concentration at the first hour. Conclusion: Heparin induces apoptosis in lymphoblasts and intracellular Ca++ levels of the lymphoblasts synchronously increase with apoptosis. The increase of intracellular Ca++ level supports a concept that the mitochondria plays a role heparin-induced apoptosis in lymphoblasts.

Keywords
Heart model; Cardiomyocytes; Cardiomyogenic contraction; Test system; Cell culture; Animal reduction; 3Rs
Abbreviations
ATU: Accumulated Thermal Units; CF: Contracting Frequency; DMEM: Dulbeccos Modified Eagle Medium; EM: Electronic Microscopy; FCS: Fetal Calf Serum; RT: Room Temperature; SCC: Spontaneously Contracting Cell Aggregate
Introduction
Despite the fact that invasive/non-invasive therapies of cardiovascular disease have advanced dramatically over the last two decades, heart disease is still a major cause of morbidity and mortality in industrialized countries [1,2]. Many research groups focus on the development of cardiomyogenic models to dissect how damaged heart muscle may be repaired. Further, neovascularization of infracted myocardial tissue as well as drug treatment are topics of major importance in cardiology, as regeneration capacity of cardiomyocytes in mammals is generally low [3,4]. Any improvement of drug treatment in heart diseases will rely on the development of specific cardiac test systems.
Currently, the development of one new cardiac drug costs around 400 million US dollars [5] to ensure quality, efficacy and safety. Although there are several cardiomyogenic in vitro and in vivo models available including cell cultures [1], the testing of a new compound in high throughput test systems relies on the best option for analyzing the effects on proteins, the specificity and efficacy of a drug and also the toxicity caused by a drug. Each drug is tested on cardiomyocytes for analyzing the effect on heart activity. Therefore, it is important to know that in addition to the communication between cardiomyocytes an interaction with surrounding non-cardiomyogenic cells is present [6]. For that reason, any model for testing drugs should be complex and involve intercellular interactions as well as contain human analogue characteristics.
Currently available cardiac in vitro models are primarily cell monolayers or single cells. For that reason, during initial drug tests an analysis of influence on cell-cell interactions are not present and a limited aspect of the in vivo situation is presented [7]. Another problem is the use of test systems generated from marine organisms as several publications show that the electrophysiological properties of cardiomyocytes from mouse and rat differ significantly from human characteristics.
We developed an in vitro model that is based on spontaneously contracting cell aggregates (SCC) generated from rainbow trout larvae (Oncorhynchus mykiss, Walbaum). This 3D in vitro heart model contains fully developed heart muscle cells with cell-cell connections and a pacemaker centre. Furthermore, the use of these SCC as a human drug test system has been described as their electrophysiological properties and their reaction to drugs are similar to human cardiomyocytes [8,9]. Fish cardiomyocytes could be an alternative because of their analogy to human heart electrophysiology [10-12].
In this study, we optimized the method of SCC generation for use as a high-throughput in vitro test system. Furthermore, in line with previous studies, we examined additional structures described to be important for the evidence of cardiac functionality [13]. Such models should represent 3D cardiac tissue with interconnected cardiomyocytes exhibiting a synchronous contraction, due to complete electrical couplings.
Materials and Methods
Cell isolation
Rainbow trout larva (Oncorhynchus mykiss, Walbaum) from the beginning of the eye-point-eye stadium (at 252 ATU; ATU - accumulated thermal units; day degree) till the end of yolk sac stadium (462 ATU) were obtained from a fish farm located in Luetjenburg (Germany). ATU was calculated as the summation of the daily mean temperature of the larvae. The larvae were kept indoors at 6°C by a continuous flow of fresh water (0.15 m sec-1). The cell isolation was performed based on a procedure described by Grunow et al. [9]. For anaesthesia the larva or the carefully manually perforated egg was incubated in a 20% MS 222 (methanesulfonic acid salt; Sigma Aldrich, Germany) solution dissolved in aquarium water for 5 minutes. The larvae were dissected with scissors and digested in 500 μl 0.1% trypsin (PAA Laboratories, Austria) for one minute. Digestion was ended by addition of the triple volume of culture medium and centrifugation for five minutes at 130 g. The resulting cell pellet was resuspended in ~2 ml culture medium, seeded into 6 well culture plates (TPP, Switzerland) and cultivated at 20°C and 2.0% CO2. The culture medium was composed of DMEM (Dulbeccos Modified Eagle Medium; Gibco Germany) supplemented with 20% FCS (fetal calf serum) and 100 U/ ml Penicillin and 0.1 mg/ ml Streptomycin (PAA Laboratories, Austria). All protocols have undergone an ethical review process by the German animal welfare law §8a (ethic committee: Ministerium für Landwirtschaft, Umwelt & laendliche Raeume of Schleswig-Holstein; permit number: 41/A01/09).
Electron microscopic analysis (EM)
The aggregates were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1 h. For post fixation the SCCs were kept in 1% OsO4 in 0.1 M cacodylate buffer for 2 h. The samples were then dehydrated with ethanol and embedded in araldite (Fluka, Switzerland). Ultrathin sections were stained with uranyl acetate and lead citrate (Ultrostainer Carlsberg System, LKB, Sweden) and were examined with a Philips electron microscope EM 400 at 60 kV (Philips, The Netherlands).
Experimental procedure
Primary cultures from the SCCs were cultivated at 20°C and 2.0% CO2. During a cultivation period from three weeks up to three months medium exchange was carried out the first time two days post preparation (day 2) and then every three or four days.
To determine the rate of SCC generation as a function of developmental stage, larvae were prepared at six different time points. The developmental ratio (formation ratio) of the SCCs was determined via the relation (division) of number of developed SCCs and number of prepared larvae. At each preparation time 18 larvae were taken. The age of the prepared larvae ranged from eye-point stage (252 ATU, 294 ATU and 335 ATU) to yolk-sac stage (378 ATU, 420 ATU and 462 ATU). At around 350 ATU the rainbow trout larva is hatching. For the period of three weeks post preparation the culture dishes were microscopically checked for SCCs twice a week (Axiovert 40CFL; Germany). At the end of this observation period, the total number of SCCs was illustrated as bars. The total number of SCCs has been summed up and set up as 100%. In the bar the percental relation of cell cultures with 0, 1, 2, 3, 4 or 5 SCCs is shown. All SCCs were photographed with AxioVision (Zeiss, Germany) and filmed for 30s with Powershot A640 (Canon) via microscope adapter directly after development. The contraction frequency (CF) was calculated for one minute. The area representative for the size of the SCCs was determined via the software of AxioVision.
Temperature dependence of the beating frequency was determined over the range of 16°C to 25°C in four SCCs prepared at 350 ATU. In the experiment the starting temperature was 20°C with 2.0% CO2 incubation. This was lowered to 16°C with 1.8% CO2 and then raised to 18°C and 1.9% CO2, 20°C and 2.0% CO2, 25°C and 2.2% CO2. At the end of the experiments the CF at 20°C with 2.0% CO2 was recorded. CO2 incubation was changed for having a pH value of 7.8-7.9 in the cell culture, which was the pH of the prepared fish larva. The cells were kept for one hour at each temperature for adaptation to the new conditions. The starting CF of SCCs kept at 20°C equaled 100% and the aberration from the initial temperature was calculated as a percentage.
Statistical analysis
Data are presented as mean ± SE. Statistical analysis was performed using R-Statistik and Graph Pad Prism5. The results were tested for normality via Kolmogorov-Smirnov Test. The exclusion of a normality (p > 0.05), a Kruskal-Wallis-signed-rank-test was performed. Based on a significant effect (p < 0.05) the differences between the groups were controlled and calculated via Wilcoxon-signed-rank-test.
Results
Cell aggregate morphology and evaluation by electron microscopy
EM analysis demonstrated the SCCs were composed of fully developed cardiomyocytes. These groups of cells took on 2 primary gross structures: ball shaped (Figure 1a) or a shape that was rounded with 2-centres (Figure 1b).
Additionally, the analysis of the cardiomyogenic structures showed high concentration of mitochondria in the cytoplasm of the cardiomy-ocytes (Figure 2a). Furthermore, the T-Tubuli structures in the cells of the SCCs were located in the z-bands and next to the sarcoplasmic reticula (Figure 2b). Moreover; in the centre of every cardiomyocyte one nucleus was located (Figure 2c). The EM analysis verified structures of cell-cell connections (Figure 2d) within the SCCs.
Formation ratio, size and contractility of the SCCs
Analysis of the developmental ratio showed that the total number of SCCs followed a normal curve of distribution (p < 0.05; Kolmogorov- Smirnov Test; 252 ATU: 8 SCC; 294 ATU: 11 SCC; 335 ATU: 27 SCC; 378 ATU: 10 SCC; 420 ATU: 15 SCC; 462 ATU: 9 SCC), Figure 3a. The maximum value had a ratio of 1.5 at 335 ATU (short time before hatching), Figure 3a. At this time up to five SCC could be generated out of one fish larva. The analyses of the time of SCC development revealed that in all groups after two days (after the first medium exchange) SCCs with a ratio of 0.2 were present (Figure 3b). After nine days 75 up to 100% of all SCCs in a three-week-observation could be detected.
Another important factor for the use of a model system as a high through-put test system is the time of preparation. For example, in a 15 minute preparation the cell cultivation of six larvae was possible which means an average generation of 9 SCCs. A 96 well plate having one SCC per well could be managed in a preparation time of 2.6 hours (not included the SCC-developing time).
Size determination of the SCCs revealed a significant difference between the groups at 252 ATU and 294 ATU (p < 0.05; Kruskal-Wallissigned- rank-test), Figure 3c. The area of the SCC increased with the age of the larva. At 252 ATU the SCCs exhibit an area of 0.02 mm2. In comparison, at 462 ATU the SCCs area was four times bigger. In the other SCC-groups no significant difference between the sizes could be calculated.
To evaluate the applicability of the SCCs as human heart model, their CF has to be investigated. The studies showed a significant difference in the CF between the SCC groups of the diverse larval ages in relation to different preparation times (p < 0.05; Kruskal-Wallis signed-rank-test), Figure 3d. Comparison of the groups revealed that at 252 ATU the CF was significantly lower and at 378 ATU significantly higher compared to the other groups (p < 0.05; Wilcoxen- signed-ranktest), Figure 3d. The CF of the SCCs from other preparations did not show a significant difference (p > 0.05). Superficially, the contraction frequencies from 294 up to 462 ATU was similar or equal to the human heart frequency (60 – 80 beats/min). An analysis of the comparison between CF and size of the SCCs showed no significance (p=0.8; t-test; Figure 3e).
Another aspect for the evaluation as a test system is the stability of the frequency over a long time period. For that reason, the frequencies of SCCs from a larva at the age of 350 ATU were measured over 30 days. The SCC started to contract 12 days after preparation. The contraction of the SCC was synchronous and constant during the measurements. However, small variations between the measurements were recorded. The SCCs exhibited a frequency of 50 to 88 beats per minute (Figure 3f).
Figure 3g depicts the variance of CF of the SCCs with increasing and decreasing temperature. The CF correlated highly with temperature (p<0.001; t-test). A steady and significant increase in their frequency with increasing temperature and vice versa was observed. The maximal frequency was achieved at 25°C. The variance of the CF at 20°C did not differ between the three measurements at 20°C (at the beginning, middle and end of the temperature experiment).
Discussion
This study reports an in vitro heart model (SCC – spontaneously contracting cell aggregate) from rainbow trout with human analogue properties, which can be generated in high numbers. For the application as a test system in e.g. pharmacology the ratio of the generation of these SCCs and the time of the generation is economically important. Furthermore, for an application in human research the characteristics of the cells should be similar to human heart cells.
The detailed electron microscopical analysis revealed fully developed cardiomyocytes which exhibit myofilaments with the typical tightly packed and highly organized sarcomer structure, mitochondria in high amounts, sarcoplasmic reticulum and in the cell centre a nucleus. The high number of mitochondria indicates high metabolic activity of the cells, as they assure the aerobic metabolism.
Furthermore, we could show a co-location of the T-tubulus localization and the sarcoplasmic reticulum system similar to human heart cells (Figure 2b), [14]. This structure is important for ion exchange between cells and ion influx into the cells for generation of action potentials, however in this study this structure is only reported in small amounts. Eschenhagen et al. [13] described that in newborn rats this system is absent. We assume that in our model the larval age of the prepared fish (beginning of yolk sac stage) might be the reason for this small number. Immunocytochemical analysis published in [8,9] revealed the existence of the typical contractile proteins actin, troponinI and myosin and that the cells differentiated from progenitor cells in vitro [8]. Also, proteins of intercalated disk like β-catenin, N-cadherin and 1 & 2 desmoplakin and the gap junction proteins connexin 43 and connexin 45 in pacemaker cells could be detected. Most of the important features mentioned by Eschenhagen et al. [13] for fully developed adult cardiomyocytes are also present in the SCCs. Even if the cells of the SCC are not homologous to the human heart in every detail, it could be stated that the SCCs contain cardiomyocytes which are connected via cell-cell-contacts like adherens junctions, desmosomes and gap junctions [9] and are building up a functional syncytium which is similar to human heart tissue. The contractile function in the SCC activated by a pacemaker centre is synchronous and as a human analogue, e. g. action potential as well as effects of drugs as important for a model system are present in the SCCs [9,15-17].
Further, the study showed that SCC could be generated during the whole larval time with a maximal generation capacity immediately before hatching (325 ATU, Figure 3a,3b). At the age of 325 ATU in average 1.5 and up to five SCC were generated out of one fish larva. This result shows the possibility to generate more SCCs than animals were used. Consequently, this in vitro model has a high potential for the use as a reduction method for animal experiments and follows the 3R concept [18]. Furthermore, the preparation time of this high throughput system is possible in a very short time (96 well in 2.6 h). Another important factor for test systems is the economical costs. The preparation of a larvae and generation of SCCs from one larvae costs less than 1€. To our knowledge there is no model system in heart research available which can be generated in less time and at a low cost.
Attention should also be paid to the developmental period. From an economical point of view the generation of test system should be easy and possible in a short period. Analyses revealed that after nine days post preparation 75 rsp. 100% of all SCCs are present which were found during a three-week-observation (Figure 3b). This shows that the cultures can be used after nine days post preparation, because the development of further SCCs during the following days is economically low (labour, material and salary).
A further advantage of this model system is the 3D structure. Effects of drugs could be analyzed in cell formation and not only in single cells. This is a further step towards an in vivo like situation [7]. The area of the SCCs is dependent on the age of the prepared larva. The area of a SCC is significantly increasing from SCCs prepared from larvae at 252 ATU and 294 ATU. For other preparation times a larger aggregate size with increasing age could be measured but significance could not be proven and due to some very small SCCs. During larval fish development the heart is growing permanently [19]. We assume that the generated SCCs have a bigger size with increasing age of the prepared larva; this assumption is confirmed through subsequent analysis. Overall, the maximum area of the SCC (maximal aberration) is increasing with age. The generation of the SCC from rainbow trout seems to be limited on the larval age, resulting in a maximal size of the SCCs at the end of yolk sac stage. Depending on the study (e.g. studies of heart conditions), the user of this model should be aware of the different SCC sizes and should take SCCs of nearly the same size when comparing test groups.
The analysis of the CF in relation to the age of the larva also revealed dependence of the examined groups. The early embryonic heart of a rainbow trout has a frequency of 20 beats/ min. During the development to the eye point stage (~250 ATU) the frequency increased to 35 beats/ min [20]. At 378 ATU the larva has a 2.5 fold higher CF induced by a higher spontaneous electrical activity [19]. This CF analyses revealed that the CF of the SCCs is in accordance with data of larval CF in different developmental stages. The reason why the SCCs exhibit larval CFs and not CF of fully developed cardiomyocytes, which is present in the SCCs could be examined in further studies. One assumption is that the ion channel composition and the pacemaker centre are still larval and did not differentiate to an adult heart structure in the same manner as the anatomical part.
However, the aberrations of the CF of some SCCs could be induced by a very strong adhesive power of the surrounding cells resulting in lower CF. Higher CF could result in a temperature increase (up to 5°C higher; RT) of the medium during observation. Nevertheless, the differences in the frequency between the groups are not affecting the consistency of using this model in experiments. Users of this model should be aware of the age of the prepared larvae in advance.
The comparison of the CF in relation to the size of the SCC revealed no significant correlation. In mammals the CF is decreasing with increasing size of the organism. In this study we used larval rainbow trout. The heart of the prepared larva was not completely developed and the frequencies were changing. For that reason, we assume that in the SCCs different CFs were measured in the groups and this correlation of CF-SCC size could not be observed. Nevertheless, these analyses revealed the most important aspect: the mean CF of SCCs of preparations from 294 ATU to 462 ATU is similar to that of human and could possibly be used as a test system.
In the current study we observed aggregates with spontaneous contraction of up to six months. During a 30 day measurements, the CF was stable and human analogue (Figure 3f). The SCCs also show changes in their CF with temperature changes. A highly significant correlation was found between the CF and temperature in a range from 16 to 25°C. Rainbow trout is a eurythermal fish species which tolerates temperatures between ~0°C and 25°C in adult stage [21]. Aho et al. [22] showed that the heart rate correlated positively with temperature between 4 and 24°C in adult trout. Above 25°C the temperature declined with irregularity in the frequency. This effect could not be observed at the SCCs. Causation could be that optimal cell growth occurs at temperatures slightly higher than the temperature of the donor [23,24]. In that case an irregularity of the heart rate would be estimated at higher temperature than in fish. The cells of rainbow trout larvae do not grow at a temperature above 28°C (data not published), for that reason the effect of irregularity could not be measured. Also in other vertebrates especially mammals this effect of increasing heart rate with increasing temperature is commonly analyzed and is well known as temperature coefficient, Q10 [25].
In summary, the analysis revealed that the spontaneously contracting cell aggregates are an in vitro test system generated from fish larvae. In former studies we showed the opportunity of using the SCCs in regenerative biology because of the high regenerative potential after dissection and the possibility to propagate [8]. Furthermore, in [9] we showed the use of a pharmacological in vitro heart model system with electrophysiological properties and effects on drugs are a human analogue. In this study, the analysis of the SCC ratio and other characteristics revealed that the best preparation time is a short time before hatching. Here, in vitro models with human analogue characteristics can be generated in higher numbers than animals used, demonstrating the possibility as a robust system with a high-throughput as well as long-term assay in human and fish heart research which would support the efforts of reducing animal experiments at the same time.
Acknowledgements
The authors are grateful to the Reese Fischzucht in Helmstorf (Germany) providing the rainbow trout eggs for this project. This work was supported by the Ministry of science, economy and transport of Schleswig-Holstein and the European Community within the framework of the European Regional Development Fund (RDF).
References
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Adaptive Cell Therapy
Disc Adaptive Immunity
Disc Adipose Derived Stem Cells (ASCs)
Disc Advanced Cell Therapy
Disc Advances in Anatomy
Disc Advances in Embryology
Disc Allergy Immunology
Disc Antibody-Producing Cells
Disc Antigen-Presenting Cells
Disc Apoptotic Pathways
Disc Autologous Cell
Disc Autophagosomes
Disc Biomolecular Structure and Function
Disc Blood Cells
Disc Bone Marrow Cells
Disc Cancer Signaling Array
Disc Cancer Stem Cells (CSCs)
Disc Cell
Disc Cell Biology
Disc Cell Biology Junctions
Disc Cell Biology Techniques
Disc Cell Culture
Disc Cell Cycle
Disc Cell Death: Apoptosis
Disc Cell Receptors
Disc Cell Regeneration
Disc Cell Replacemnt Therapy
Disc Cell Signal
Disc Cell Signaling Mechanisms
Disc Cell Signaling Pathways
Disc Cell Therapy Bioprocessing
Disc Cell Therapy Products
Disc Cell motility
Disc Cell synthesis
Disc Cell tracking
Disc Cell-Biology
Disc Cellular Biology
Disc Cellular Communication
Disc Cellular DNA Studies
Disc Cellular Dynamics
Disc Cellular Immunology
Disc Cellular Ligands
Disc Cellular Oncogenes
Disc Cellular Signalling
Disc Cellular and Molecular Biology
Disc Centrioles
Disc Clinical Immunology
Disc Crynofacial Genetics
Disc Cytoskeleton
Disc DNA-based barcodings
Disc Dendritic Cell Therapy
Disc Dental Stem Cells
Disc Developmental Biology
Disc Diagnostic Immunology
Disc Embryonic Stem Cells (ESCs)
Disc EnteroEndocrine Cells
Disc Epithelial Cells
Disc Erythroid Cells
Disc Evolutionary Immunology
Disc Extracellular signaling
Disc Fetal Stem Cell Therapy
Disc Gene Expression and Regulation
Disc Germ Cells
Disc Hair Follicle Cells
Disc Hematology
Disc Hematopoietic Stem Cells (HSCs)
Disc Histology of Cell Biology
Disc Human Embryology
Disc Immune Cell Therapy
Disc Immuno Cell biology
Disc Inflammatory Disorders
Disc Intracellular Signaling
Disc Lipid Signaling Pathways
Disc Live Cell Therapy
Disc Mapk Pathway Cell Signaling
Disc Membrane Trafficking
Disc Mesenchymal Cells
Disc Mesenchymal Stem Cells
Disc Methods and Techniques in Molecular Biology
Disc Molecular Biochemistry
Disc Molecular Biotechnology
Disc Molecular Cell
Disc Molecular Genetics
Disc Molecular Signaling
Disc Multipotent Stem Cells
Disc Myeloid Stem Cells
Disc NO Signaling and Ion Channels
Disc Neural Stem Cells (NSCs)
Disc Neuroinflammatory Disorders
Disc Ocular Immunology and inflammation
Disc Ovation cell therapy
Disc Plant Cells
Disc Plant Stem Cells
Disc Pluripotent Stem Cells
Disc Polymerization
Disc Recombinant Cytokines
Disc Scaffold Signaling Proteins
Disc Signal Transduction
Disc Signal Transduction Cascades
Disc Signaling Systems
Disc Single Cell Analysis
Disc Single Cell Gene Expression
Disc Single Cell Genome
Disc Single Cell Protein
Disc Single cell Imaging
Disc Single cells
Disc Skin Cell Therapy
Disc Somatic Cell Therapy
Disc Stem Cell
Disc Stem Cell Biology
Disc Stem Cell Preservation
Disc Stem Cell Therapy for Diabetes
Disc Stem Cell Therapy for Osteoarthritis
Disc Stem Cell Transplant
Disc Stem Cells
Disc Tissue
Disc Totipotent Stem Cells
Disc Transcription
Disc Translational Immunology
Disc Transplantation Immunology
Disc Tumor Immunology
Disc Vaccine Immunology
Disc Viral Immunology
 
Recommended Journals
Disc Cell Signaling journal
Disc Cancer Research Journal
Disc Cell Science Journal
Disc Clinical and Laboratory Research Journal
Disc Clinical & Cellular Immunology Journal
Disc Molecular Biology Journal
Disc Cell Biology Journal
Disc Single Cell Biology Journal
Disc Stem Cell Research Journal
  View More»
 
Recommended Conferences
Disc 4th Plant Genomics
July 14-15, 2016 Brisbane, Australia
Disc 5th Tissue Science and Regenerative Medicine Conference
September 12-14, 2016 Berlin, Germany
Disc 3rd World Congress on Women’s Health and Breast Cancer

October 03-05, 2016 London, UK
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11288
  [From(publication date):
February-2012 - May 27, 2016]
  Breakdown by view type
  HTML page views : 7562
  PDF downloads :3726
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version